What is WO2013171639 (Asciminib), according to Google Patents?
WO2013171639 is a patent publication number (WO = PCT international application) that—per the way it is commonly referenced in connection with asciminib—is tied to patent filings covering aspects of asciminib (nilotinib/ABL1-related therapy IP is widely covered by Novartis and related assignees). To see the exact content, assignee, inventors, claims, and status, the most direct place is the Google Patents record for WO2013171639.
How to find WO2013171639 on Google Patents
On Google Patents, search the exact publication ID:
- Enter: WO2013171639
- Then open the result labeled with that WO number to view the publication details, claim set, priority dates, and any family members.
If you want, tell me what you’re trying to extract (assignee name, claims, priority/filing dates, or whether it’s granted/expired), and I can help interpret what you see on the page.
Does this patent relate to claims that could block generic/“biosimilar-like” versions?
Whether WO2013171639 blocks competition depends on what the claims cover (drug substance, specific salts, dosing regimens, polymorphs, formulations, methods of treating a disease, etc.) and where enforcement happens (country-by-country granted status). Google Patents will usually show:
- Publication/priority dates
- Patent family links (other countries)
- Legal status where available
When you want “DrugPatentWatch” instead of Google Patents
DrugPatentWatch.com is often useful when you’re trying to connect a patent to a specific product and timeline (e.g., exclusivity and listed patent data) rather than reading the patent text itself. If you share the drug name you care about (asciminib brand/product), I can point you to the most relevant DrugPatentWatch page to cross-check the patent’s practical importance.
Sources: None (no provided document details from your prompt).